The authors have studied 300 cases of atopic dermatitis at children being at the age of 3 — 18. Based on the medical documentation analysis and questioning, they ascertained high cost of the disease both for the family and the state. Structure and amount of costs depended on duration and severity of the disease. On the whole, the authors point out that atopic dermatitis has negative impact upon life quality of the patients and their families, nevertheless there is a need to carry out further pharmacoeconomic researches.